The study by Sari Reisner and colleagues1 in The Lancet HIV on gender-affirming hormone therapy and its effect on HIV ...
Lupron and other LHRH agonists are forms of hormone-blocking therapy. For people with prostate cancer, hormone-blocking therapy aims to reduce testosterone levels in the body. Male hormones ...
MONDAY, March 10, 2025 (HealthDay News) -- Hormone replacement therapy during menopause appears to be linked to a toxic brain protein that’s a hallmark of Alzheimer’s disease. Women over 70 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback